1 Department of Radiology, Research Institute of Radiological Science, Medical Convergence Research Institute, and Severance Biomedical Science Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
2 Department of Radiology, National Health Insurance Service Ilsan Hospital, Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of Korea.
AJR Am J Roentgenol. 2017 Oct;209(4):867-873. doi: 10.2214/AJR.17.17938. Epub 2017 Aug 10.
The objective of our study was to compare subtrochanteric femur bone mineral density (BMD) and bone quality of long-term bisphosphonate (BP) users who sustained an atypical femoral fracture (AFF) with BP users who did not sustain a femoral fracture and BP-naïve patients with no history of femoral fracture using quantitative CT (QCT).
Fourteen female BP users with an AFF (mean age, 72.6 years; mean duration of BP use, 6.2 years; mean body mass index, 21.9) who had undergone QCT before fracture events were sex-, age-, BP use duration-, and body mass index-matched to 14 BP users who did not sustain a fracture and 14 BP-naïve patients. The lateral cortical thickness index (CTI) and the mean BMD (BMD) and SD of the BMD (BMD) within the lateral cortex and within the entire cross-sectional area of the subtrochanteric femur were measured on axial QCT. Femoral neck-shaft angles were measured on the QCT scout image. Parameters were analyzed using the Kruskal-Wallis test.
Lateral CTIs were greater in the BP users with an AFF (median, 0.28) than in the BP users without a femoral fracture (median, 0.21) (p = 0.038) and the BP-naïve group (median, 0.21) (p = 0.009). The lateral cortex BMD was significantly higher in the BP users with an AFF (median, 59.59 mg/cm) than the BP users without a femoral fracture (median, 39.27 mg/cm; p = 0.049) and the BP-naïve group (median, 31.02 mg/cm; p = 0.037). There was no significant difference among groups in lateral cortex BMD, BMD and BMD of the entire cross-sectional area, and femoral neck-shaft angle.
Long-term BP users with a subsequent AFF had a thicker lateral cortex and higher lateral cortex BMD at the subtrochanteric area before the fracture on QCT than BP users who did not sustain a femoral fracture and BP-naïve patients.
我们的研究目的是使用定量 CT(QCT)比较长期使用双膦酸盐(BP)且发生非典型股骨骨折(AFF)的患者、未发生股骨骨折的 BP 使用者和无股骨骨折史的 BP 初治患者的转子下股骨骨矿物质密度(BMD)和骨质量。
14 名女性 AFF 患者(平均年龄 72.6 岁;BP 使用时间平均 6.2 年;平均 BMI 21.9)在骨折前接受 QCT 检查,按性别、年龄、BP 使用时间、BMI 与 14 名未发生骨折的 BP 使用者和 14 名 BP 初治患者相匹配。在轴向 QCT 上测量外侧皮质厚度指数(CTI)和外侧皮质内的平均 BMD(BMD)和 BMD 的标准差(SD)以及整个转子下股骨横截面积内的 BMD。在 QCT 扫描图像上测量股骨颈干角。使用 Kruskal-Wallis 检验分析参数。
AFF 患者的 BP 使用者(中位数 0.28)的外侧 CTI 大于未发生股骨骨折的 BP 使用者(中位数 0.21)(p = 0.038)和 BP 初治组(中位数 0.21)(p = 0.009)。AFF 患者的 BP 使用者(中位数 59.59mg/cm)的外侧皮质 BMD 显著高于未发生股骨骨折的 BP 使用者(中位数 39.27mg/cm;p = 0.049)和 BP 初治组(中位数 31.02mg/cm;p = 0.037)。三组患者的外侧皮质 BMD、整个横截面积的 BMD 和 BMD 以及股骨颈干角无显著差异。
在 QCT 上,与未发生股骨骨折的 BP 使用者和 BP 初治患者相比,发生后续 AFF 的长期 BP 使用者在骨折前转子下区域的外侧皮质较厚,外侧皮质 BMD 较高。